Abstract
The effects of intravenous administration of nedocromil sodium were investigated in active and passive models of conjunctival immediate hypersensitivity in rats. In the active sensitization model, animals were immunized with ovalbumin 21 days prior to ocular instillation of a solution containing ovalbumin. Nedocromil sodium administered prior to antigen challenge significantly inhibited emergence of conjunctival edema and erythema (P < .05) and reduced mast cell degranulation (P < .02). In the passive-sensitization model, the conjunctiva in one eye was injected with ovalbumin antiserum 48 hours prior to intravenous administration of ovalbumin. Nedocromil sodium administered prior to antigen challenge significantly and dose-dependently reduced appearance of the signs of conjunctivitis (P < .01) as well as vascular leakage (P < .05). These data indicate that intravenous nedocromil sodium is effective in animal models of allergic conjunctivitis and may have potential for wider therapeutic application. These data are also consistent with results of clinical studies in which nedocromil sodium relieved symptoms of allergic conjunctivitis and further support a role for nedocromil sodium in the prevention of allergic conjunctivitis.
Similar content being viewed by others
References
Doherty MJ, Easty DL. Inflammatory and immunological cell profiles in a rat model of conjunctival immediate hypersensitivity.Clin Exp Allergy. 1989; 19: 449–455.
Levine BB, Vaz NM. Effect of combinations of inbred strain, antigen, and antigen dose on immune responsiveness and reagent production in the mouse. A potential mouse model for immune aspects of human atopic allergy.Int Arch Allergy Appl Immunol. 1970; 39: 156–171.
Layton GT, Stanworth DR. The quantitation of IgG4 antibodies to three common food allergens by ELISA with monoclonal anti-IgG4.J Immunol Methods. 1984; 73: 347–356.
Udaka K, Takeuchi Y, Movat HZ. Simple method for quantitation of enhanced vascular permeability.Proc Soc Exp Biol Med. 1970; 133: 1384–1387.
Dahlen SE, Bjorck T, Kumlin M, et al. Dual inhibitory action of nedocromil sodium on antigeninduced inflammation.Drugs. 1989; 37(suppl 1): 63–68.
Kjellman NI, Stevens MT. Clinical experience with Tilavist: an overview of efficacy and safety.Allergy. 1995; 50: 14–22.
Alexander M. Comparative therapeutic studies with Tilavist.Allergy. 1995; 50: 23–29.
Verin P. Treating severe eye allergy.Clin Exp Allergy. 1998; 28 (suppl 6): 44–48.
Merayo-Lloves J, Zhao TZ, Dutt JE, Foster CS. A new murine model of allergic conjunctivitis and effectiveness of nedocromil sodium.J Allergy Clin Immunol. 1996; 97: 1129–1140.
Calonge M, Montero JA, Herreras JM, Juberias JR, Pastor JC. Efficacy of nedocromil sodium and cromolyn sodium in an experimental model of ocular allergy.Ann Allergy Asthma Immunol. 1996; 77: 124–130.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
McGrath, L.E.V., Doherty, M.J., Easty, D.L. et al. Nedocromil sodium in two models of conjunctival immediate hypersensitivity. Adv Therapy 17, 7–13 (2000). https://doi.org/10.1007/BF02868026
Issue Date:
DOI: https://doi.org/10.1007/BF02868026